» Articles » PMID: 27640517

Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression

Overview
Date 2016 Sep 20
PMID 27640517
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

The autonomic nervous system is one of the major neural pathways activated by stress. In situations that are often associated with chronic stress, such as major depressive disorder, the sympathetic nervous system can be continuously activated without the normal counteraction of the parasympathetic nervous system. As a result, the immune system can be activated with increased levels of proinflammatory cytokines. These inflammatory conditions have been repeatedly observed in depression. In the search for the mechanism by which the immune system might contribute to depression, the enhanced activity of indoleamine 2,3- dioxygenase by pro-inflammatory cytokines has been suggested to play an important role. Indoleamine 2,3-dioxygenase is the first enzyme in the kynurenine pathway that converts tryptophan to kynurenine. Elevated activity of this enzyme can cause imbalances in downstream kynurenine metabolites. This imbalance can induce neurotoxic changes in the brain and create a vulnerable glial-neuronal network, which may render the brain susceptible to depression. This review focuses on the interaction between stress, the autonomic nervous system and the immune system which can cause imbalances in the kynurenine pathway, which may ultimately lead to major depressive disorder.

Citing Articles

Possible antidepressant mechanism of acupuncture: targeting neuroplasticity.

Xu N, He Y, Wei Y, Bai L, Wang L Front Neurosci. 2025; 19:1512073.

PMID: 40018358 PMC: 11865234. DOI: 10.3389/fnins.2025.1512073.


The Human Superficial Fascia: A Narrative Review.

Fede C, Clair C, Pirri C, Petrelli L, Zhao X, Sun Y Int J Mol Sci. 2025; 26(3).

PMID: 39941057 PMC: 11818326. DOI: 10.3390/ijms26031289.


Autonomic Changes Associated with Clinical Depression as Assessed by Short-term Heart Rate Variability (HRV): A Comparative Study.

Shanmugavaradharajan V, Ravikumar R, Raghav B , Anand I Indian J Psychol Med. 2024; :02537176241265490.

PMID: 39564246 PMC: 11572687. DOI: 10.1177/02537176241265490.


What can the psychoneuroimmunology of yoga teach us about depression's psychopathology?.

Chiarpenello C, Brodmann K Brain Behav Immun Health. 2024; 42:100877.

PMID: 39430877 PMC: 11489066. DOI: 10.1016/j.bbih.2024.100877.


Maternal and fetal neurocognitive outcomes in preeclampsia and eclampsia; a narrative review of current evidence.

Kokori E, Aderinto N, Olatunji G, Komolafe R, Abraham I, Babalola A Eur J Med Res. 2024; 29(1):470.

PMID: 39342384 PMC: 11437679. DOI: 10.1186/s40001-024-02070-5.


References
1.
Najjar S, Pearlman D, Alper K, Najjar A, Devinsky O . Neuroinflammation and psychiatric illness. J Neuroinflammation. 2013; 10:43. PMC: 3626880. DOI: 10.1186/1742-2094-10-43. View

2.
Myint A, Kim Y, Verkerk R, Scharpe S, Steinbusch H, Leonard B . Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord. 2006; 98(1-2):143-51. DOI: 10.1016/j.jad.2006.07.013. View

3.
Lugo-Huitron R, Blanco-Ayala T, Ugalde-Muniz P, Carrillo-Mora P, Pedraza-Chaverri J, Silva-Adaya D . On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress. Neurotoxicol Teratol. 2011; 33(5):538-47. DOI: 10.1016/j.ntt.2011.07.002. View

4.
Moffett J, Namboodiri M . Tryptophan and the immune response. Immunol Cell Biol. 2003; 81(4):247-65. DOI: 10.1046/j.1440-1711.2003.t01-1-01177.x. View

5.
Bertini R, Garattini S, Delgado R, Ghezzi P . Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology. 1993; 79(2):217-9. PMC: 1421854. View